ReviewBest practice & research. Clinical endocrinology & metabolism2017

The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer.

Valentina De Falco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.